Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Healthy Volunteers

NCT03641794 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: DN1406131
DRUG: Placebo

Sponsor

Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Collaborators

[object Object]